Content uploaded by Mankaran Singh
Author content
All content in this area was uploaded by Mankaran Singh
Content may be subject to copyright.
Singh Mankaran et al. Int. Res. J. Pharm. 2013, 4 (3)
Page 45
INTERNATIONAL RESEARCH JOURNAL OF PHARMACY
www.irjponline.com ISSN 2230 – 8407
Review Article
TYPHONIUM FLAGELLIFORME: A MULTIPURPOSE PLANT
Singh Mankaran*, Kumar Dinesh, Sharma Deepak, Singh Gurmeet
Research Scholar, CT Institute of Pharmaceutical Sciences, Department of Pharmaceutics, Shahpur, Jalandhar, Punjab, India
Email: mankaran_220@yahoo.com
Article Received on: 19/01/13 Revised on: 08/02/13 Approved for publication: 12/03/13
DOI: 10.7897/2230-8407.04308
IRJP is an official publication of Moksha Publishing House. Website: www.mokshaph.com
© All rights reserved.
ABSTRACT
Typhonium flagelliforme is a prominent plant candidate from aroid family, endowing various curative properties against a variety of illness and infections.
This tropical plant found in damp, shady habitats and population of south east asian countries used it as alternative curative health supple ment. Traditionall y,
this plant is used as a alternative remedy for cancer. Also, anti bacterial and antioxidant activities are well established. This plant has shown promising results
as a cough suppressant, which can be helpful in various respiratory tract problems. This review focuses on various biological activities of Typhonium
flagelliforme.
Keywords: Typhonium flagelliforme, Anticancer, Antibacterial, Antioxidant, Chemical Constit uents
INTRODUCTION
Herbs are staging a comeback and herbal ‘renaissance’ is
happening all over the globe. The herbal medicines today
symbolize safety in contrast to the synthetics that are
regarded as unsafe to human and environment. The past two
decades have seen a worldwide upsurge in the use of
traditional medicine (TM) and complementary and
alternative medicine (CAM) in both developed and
developing countries. Although herbals had been priced for
better compatibility with the human body, lesser side effects
and better cultural acceptability, about 75–80% of the world
population, showed interest and relies mainly on plants and
plant extracts for their primary health care1.
A plant from Malaysian lowlands got recent taxonomic and
pharmacological attention2. Typhonium flagelliforme is an
entire medicinal herb which belongs to the Araceae
(Arum) family, commonly known as ‘rodent tuber’ in
Malaysia. This plant grows widely in disturbed wastelands
including soft, damp and shady habitats. And is native to the
South East Asian countries and the southern part of India and
Sri Lanka to Australia.2, 3, 4.
Typhonium flagelliforme plant can grows up to 30 cm in
height and has yellow coloured spadix enclosed in spathe,
leaves are triangular in shape and tubers are whitish and
oblong3. The spathe is 15.37 ± 1.17 cm long and 1.44 ±
0.07 cm broad at the widest portion. The spadix is
divided into four portions: a lower 0.41±0.03 cm pistillate
portion, an intermediate 1.48 ± 0.14 cm portion with sterile
flowers, a 0.34 ± 0.05 cm staminate portion and
terminated with lemon yellow 12.92 ± 1.25 cm rodent tail-
like appendix 5.The distinguishing feature of araceae family
which is bizarre combination of spathe and spadix which is
useful in trappment of pollinators because of their particular
morphology and organization of their inflorescences.
Southern-east asian countries including India and China used
this traditional plant from years for alternative cancer
therapies. Typhonium flagelliforme is potential healthcare
supplement to cure breast, lung, rectum, liver, prostate,
pancreas and cervical cancers and leukemia’s 2.
Being endowed with detumescence, detoxification, anti-
inflammation, antivirus and anticancer bioactivities, plant is
usually taken orally for treatment of cough, asthma and to
soothe swelling of respiratory tract. To sweeten and increase
patient acceptability, juice of the fresh whole plant is mixed
with honey. Also, leaves are wrapped in longan flesh and
taken raw 3, 6, 7, 8. The flowers of T. flagelliforme have been
used as anticoagulant by ‘Filipinos’ and Chinese used this
plant as remedial for the treatment of injury4. Antibacterial
and antioxidant activities of T. flagelliforme were reported in
tuber extracts 6.
Chemical Constituents
In order to assess its phytochemical components, an
experiment was conducted on one to six month old ex vitro
and in vitro extracts of T. flagelliforme. The active (ex vitro
and in vitro) extracts of T. flagelliforme were screened for
phytochemicals components such as alkaloids, flavonoids,
terpenoids and steroids. Alkaloids and flavonoids are the
main phytochemical constituents of T. flagelliforme which
are found to be in the highest amount in two and four month
old of ex vitro plants. High amounts of main phytochemical
constituents were observed during the flowering process
which started in two month old plant and finished at the end
of the three month old plant5. The other phytoconstituents
include chain of saturated fatty acids like methyl esters of
linoleic acid9, hexadecanoic acid, octadecanoic acid, 9-
octadecenoic acid and 9, 12-octadecadienoic acid. In
addition, several common aliphatics were identified as
dodecane, tridecane, tetradecane, pentadecane, hexadecane,
heptadecane, octadecane, nonadecane and eicosane. None of
the above identified compounds showed or are known to have
cytotoxic behavior2. A variety of intercellular and
extracellular enzymes also present in T. flagelliforme include
peroxidase, laccase, tyrosinase, reductase, azo reductase, and
riboflavin reductase10. Other include an acyclic diterpene
alcohol, phytol and amino acids like arginine, tryptophan
were also reported in different studies11, 3. In addition,
phenylpropanoid glycosides, sterols and a cerebroside were
also found in the root of this plant2.
Therapeutic Activities of Typhonium flagelliforme
It is a medicinal herb which is endowed with curative
properties against a variety of illness including injuries,
oedema, pulmonary ailments and bleeding5.
Singh Mankaran et al. Int. Res. J. Pharm. 2013, 4 (3)
Page 46
Anticancer Activity
Antiproliferative action
Typhonium flagelliforme have been reported to act as
anticancer in a recent study conducted in Centre for Drug
Research, University Sains Malaysia with School of
Chemical Sciences, Malaysian Institute of Pharmaceuticals
and Nutraceuticals, Ministry of Science Technology and
Innovation collaboration by Choon-Sheen Lai et al. They
investigated antiproliferative activity of plant in vitro on a
human lung carcinoma cell line (NCI-H23) and a non-
tumorigenic fibroblast cell line (BALB/c 3T3) using the
bioactivity guided approach. For that, extracts of typhonium
flagelliforme were fractioned by using flash column
chromatography and each fraction was evaluated for
antiproliferative activity using MTT assay. The apoptotic
effect of the active fraction was determined microscopically
and by using TUNEL colorimetric assay. GC–MS
(Hyphenated gas chromatography and mass spectrometry)
and NMR (1H NMR) were used to determine the chemical
constituents of this active fraction. Finally studies revealed
that Several fractions of the hexane and dichloromethane
extracts were found to inhibit the growth of NCI-H23 non-
small cell lung carcinoma cell line significantly, with IC50
<15µg/ml (IC50 means half maximal inhibitory
concentration). However most of these active fractions were
also found to inhibit the growth of non-tumorigenic BALB/c
3T3 mouse fibroblast cell line except for fraction 21 of the
dichloromethane extract (D/F21). This particular fraction was
not only less cytotoxic to the non-tumorigenic cells where the
IC50 was 48.6µg/ml compared to IC50 7.5µg/ml for NCI-H23,
but it was also found to induce apoptosis in the cancer cell
line. GC–MS analysis revealed that D/F21 contains
hexadecanoic acid, 1-hexadecene, phytol and a derivative of
phytol. The presence of non-saturated fatty acids in this
fraction was confirmed by nuclear magnetic resonance
spectroscopy3.
Cytotoxic activity
This plant was often included as an essential ingredient in
various herbal remedies recommended for cancer therapies in
Malaysia. Choo et al. performed an experiment which proved
cytotoxic activity of T. flagelliforme. Experimentation
methodology include testing of activity on murine P388
leukaemia cells using the MTT assay method. Various
extracts prepared from either the roots, tubers, stems or
leaves for research purpose. Both the chloroform (IC50 = 6.0
microg/mL) and hexane (IC50 = 15.0 microg/mL) extract
from the 'roots and tubers' exhibited weak cytotoxic activity.
The hexane extract (IC50 = 65.0 microg/mL) from the 'stems
and leaves' exhibited weaker cytotoxic activity than the
chloroform extract (IC50 = 8.0 microg/mL). Further analysis
using an amino acid analyser revealed that the juice extract
contained a high concentration of arginine (0.874%). A high
tryptophan content (0.800%) was confirmed by NMR and
HPLC analysis11.
For cytotoxic action one more study was performed by
Mohan et al, to investigate the potential in vitro cytotoxic
effect of leaves and tubers of T. flagelliforme extracts against
human T4-lymphoblastoid cell line CEM-ss. Only
Dichloromethane and Ethyl acetate extracts of T.
flagelliforme showed significant anti proliferative effect
against CEM-ss cells, from eight extracts. Finally concluded
that T. flagelliforme appears to be a promising plant
demonstrating anti cancer activity 8.
Induction of Apoptosis
Induced by linoleic acid fraction of Typhonium
flagelliforme in human T4 lymphoblastoid (CEMss)
A study was conducted by Syam Mohan et al which
confirmed anti-leukemic activity by preparing Typhonium
flagelliforme dichloromethane extract from tubers and tested
on human T4 lymphoblastoid (CEMss) cell line. The
dichloromethane (DCM) extract of tuber has been
fractionated by column chromatography and evaluated for its
cytotoxicity toward CEMss cells as well as human primary
blood lymphocytes (PBLs). Phase-contrast Inverted
Microscopy, SEM, TEM were used to assess Apoptosis and
terminal deoxynucleotidyl transferase dUTP nick end
labeling (TUNEL) assay was used for further confirmation of
apoptosis. The data revealed that only few fractions showed
significant cytotoxicity against the selected cell line CEMss,
in which fractions DCM/F7, DCM/F11 and DCM/F12
showed exceptional activity. Further studies in the non-
cancerous PBL (primary blood lymphocytes) exhibited
significant selectivity of DCM/F7 compared to other
fractions. Double-staining of acridine orange (AO)/propidium
iodide (PI), SEM and TEM were collectively used to confirm
cytological observations showed events like chromatin
condensation, cell shrinkage, abnormalities of cristae,
membrane blebbing, cytoplasmic extrusions and formation of
apoptotic bodies. Results indicate that T. flagelliforme
possess a valuable anti-leukemic effect and was able to
produce distinctive morphological features of cell death that
corresponds to apoptosis2.
Figure 1: Inhibition effffffffects of selected fraction (DCM/F7, DCM/F11 and DCM/F12) on proliferated human peripheral blood lymphocytes 2
Singh Mankaran et al. Int. Res. J. Pharm. 2013, 4 (3)
Page 47
Apoptotic effect on murine leukemia WEHI-3 cells
This plant had shown to induce antiproliferative effect as well
as apoptosis in cancer cells. Mohan et al. got success, when
they investigate in vitro and in vivo effects of Typhonium
flagelliforme on murine leukemia WEHI-3 cells. It was found
that various extracts of Typhonium flagelliforme were used to
detect in vitro inhibition of growth of leukemia cells. Only
dichloromethane (DCM) tuber extracts had demonstrated
apoptogenic effect when observed under fluorescent
microscope. The results showed that the counts of immature
granulocytes and monocytes were significantly decreased in
peripheral blood of BALB/c leukemia mice after the oral
administration of DCM tuber extracts of TF for 28 days with
three doses (200, 400 and 800 mg/kg). These results were
confirmed by observing the spleen histopathology and
morphology of enlarged spleen and liver in leukemia mice
when compared with the control. Furthermore, the cell death
mechanism in the spleen tissue of treated mice was found via
apoptosis12. Mechanistic approach from Syam Mohan et al
revealed that activation of caspase-3 and-9, PARP cleavage
and cytochrome C release were responsible for induction of
apoptosis in CEMss cells13.
Typhonium flagelliforme was not efficient to destroy every
cell-line, an in-vitro cytotoxicity screening of the Typhonium
flagelliforme extracts indicated high cytotoxicity effect on
human lung carcinoma NCI-H23 cells and human mammary
gland carcinoma T-47D cells, but the extracts were not active
on human liver carcinoma HepG2 cells14.
Antibacterial Activity
Both leaves and tubers of Typhonium flagelliforme exhibits
antibacterial activity. Researchers used cold macerated
extracts of solvents in the order of increasing polarity. The
extraction was done for 7 days and evaluated. Finally, they
found that only hexane extract shown anti bacterial activity
against the selected strains. The hexane extract from
Typhonium flagelliforme tuber had interesting activity
against both the gram negative bacteria, Pseudomonas
aeruginosa (11±1.0 mm diameter) and Salmonella
choleraesuis (12±1.1 mm diameter). The positive control,
Streptomycin had shown zone of inhibition of 20±1.5
mm, 20±1.3 mm, 23±1.5 mm and 23±1.0 mm in
Methicillin Resistant Staphylococcus aureus, Pseudomonas
aeruginosa, Salmonella choleraesuis and Bacillus subtilis
respectively6.
The same experiment was performed for Typhonium
flagelliforme leaves using same conditions and leaves’
hexane extract was capable to show antibacterial activity
against Pseudomonas aeruginosa 7.
Antioxidant Activity
For testing the antioxidant activity, Researchers used two
methods namely DPPH (2, 2-diphenyl-2-picrylhydrazyl
hydrate) free radical scavenging and total phenolic
compounds, were used for the antioxidant analysis. All the
extracts were subjected to screening for their possible
antioxidant activity. The DPPH assay showed that the
inhibitory activity of ethyl acetate (77.6±0.9%) and
dichloromethane (70.5±1.7%) extracts were having
comparatively admirable inhibition capacity when
compared to the positive control BHT (95.3±1.3%). Total
phenolic content of all extracts was also evaluated, and
dichloromethane extracts (5.21±0.82 GAE mg/g extract) was
superior to all other extracts, followed by hexane (3.27±0.85
GAE mg/g) and ethyl acetate (2.49±0.33 GAE mg/g)(Mohan
et. al, 2008). Above experiment was related with Typhonium
flagelliforme tubers and same experiment was performed for
Typhonium flagelliforme leaves using same conditions and
results shows the Total phenolic content of Methanol
extracts(5.69±0.15 GAE mg/g extract) was superior to all
other extracts, followed by dichloromethane (5.31±0.82 GAE
mg/g) and ethyl acetate (4.24±0.26 GAE mg/g)6-7.
Seeing all above results Typhonium flagelliforme appears to
be a promising plant demonstrating antibacterial and
antioxidant activity that requires further investigation.
Miscellaneous Activities
Typhonium flagelliforme is plant with various
pharmacological activities. Zhong et al performed an
experiment in Guangxi Institute of Traditional Medical and
Pharmaceutical Sciences, Nanning which shows that All the
water, alcohol and ester extracts of Typhonium flagelliforme
could significantly decrease cough times, increase phenol red
outage in trachea, prolong asthma incubation period, decrease
twisting times, inhibit ear swelling and decrease autonomic
action times. Finally, they concluded that All water, alcohol
and ester extracts of TFB have effects of relieving a cough,
eliminating expectoration, antiasthmatic, analgesia, anti-
inflammation and sedation15.
CONCLUSION
Typhonium flagelliforme is a multipurpose plant having a
great potential as anticancer, antioxidant, antibacterial and
cough suppressant. In addition to being good candidate for
acquiring various properties, efforts are being in process
which can make it as new hope in therapeutics.
REFERENCES
1. Kamboj, VP. Herbal medicine. Current Sci ence. 2000; 78(1):35 -39.
2. Mohan S, Bustamam A, Ibrahi m S, Al-Zubairi AS, Aspollah M,
Abdullah R, El hassan MM. n vitro Ultramorphological Assessment of
Apoptosis on CEMss Induced by Linoleic Acid-rich Fraction fro m
Typhonium flagelliforme Tuber. Evidence-Based Complementary and
Alternative Medicine. 2011:1-12. http://dx.doi.org/
10.1093/ecam/neq010 PMid:21785623 PMCid:3135625
3. Lai CS, Masb RHMH, Naira NK, Majidc MIA, Mansora SM,
Navaratnama V. Typhonium flagelli forme inhibits cancer cell growth in
vitro and induces apoptosis: An evaluation by the bioactivity guided
approach. Journal of Et hnopharmacology. 2008; 118: 14–20.
http://dx.doi.org/10.1 016/j.jep.2008.02.034 PMid:18436400
4. Nobakht GM, Kadir MA, Stanslas J. In vitro mass propagation of
Typhonium flagel liforme as affected by plant growth regulators. African
Journal of Biotechnology. 2009; 8 (24): 6840-6843.
5. Nobakht GM, Kadi r M A, Stanslas J. Analysis of preli minary
phytochemical screening of Typhonium flagelliforme. African Journal
of Biotechnology.2010; 9 (11): 1655-1657
6. Mohan S, Abdul AB, Wahab SIA, Al-Zubairi AS, El hassan MM, Yousif
M. Antibacterial and Antioxidant Activities of Typhonium Flagelliforme
(Lodd.) Blume Tuber. American Journal of Biochemistry and
Biotechnology. 2008; 4 (4): 402-407. http://dx.doi.org/
10.3844/ajbbsp.200 8.402.407
7. Mohan S, Abdul AB, Wahab SIA, Al-Zubairi AS, El hassan MM, Yousif
M. Investigati ons of Antioxidant and Antibact erial Activities of
Typhonium Flagelliforme (Lodd.) Blume Leaves. Research Journal of
Pharmacology.200 8; 2(4):47-51.
8. Mohan S, Bustamam A, Ibrahi m S, Al-Zubairi AS, Aspollah M.
Anticancerous Effect of Typhonium flagelliforme on Human T4-
Lymphoblastoid Cell Line CEM-ss. Journal of Pharmacology and
Toxicology. 2008; 3(6): 449-456. http://dx.doi.org/
10.3923/jpt.2008.449.456
9. Choo CY, Cha n KL, Sam TW, Hitotsuyanagi Y, Takeya K. The
cytotoxicity and chemical constituents of the hexane fraction of
Typhonium flagelliforme(Araceace). Journal of Ethnopharmacology.
2001; 77(1):129-31. http://dx.doi.org/10.1016 /S0378-8741(01)00274-4
10. Kagalkar AN, Jagtap UB, Jadhav JP, Govindwar SP, Bapat VA. Studies
on phytoremediation potentiality of T yphonium flagelli forme for the
degradation of Brilliant Blue R. Planta. 2010; 232:271–285.
http://dx.doi.org/10.1 007/s00425-010-1157-2 PMid:20437182
Singh Mankaran et al. Int. Res. J. Pharm. 2013, 4 (3)
Page 48
11. Choo CY, Chan KL, Takeya K, Itokawa H. Cytotoxic activity of
Typhonium fl agelliforme (Araceae). Phytotherapy Research. 2001;
15(3):260-2. http://dx.doi.org/10.1002/ptr.717 PMid:11351365
12. Mohan S, Abdulab AB, Abdel wahaba SI, Al-Zubairi AS, Sukarid MS,
Abdullahe R, Tahaa MME, Benga NK, Isaa NM. Typhonium
flagelliforme inhibits the proliferation of murine leukemia WE HI-3 cells
in vitro and induces apoptosis in vivo. Leukaemia Research.2010;
34(11): 1483-1492. http://dx.doi.org/10.1016/j.leukres.2010.04.023
PMid:20569984
13. Mohan S, B ustamam A, Abdelwahab SI, Al-Zubairi AS, Aspollah M,
Abdullah R, Elhassan MM, Ibrahim MY, Syam S. Typhonium
flagelliforme ind uces apoptosis in C EMss cells via activation of
caspase-9, PARP cleavage and cytochrome c release: Its activation
coupled with G0/G1 phase cell cycle arrest. J Ethnopharmaco. 2010;
131(3):592-600. http://dx.doi.org/10.1016/j.jep.2010.07.043
PMid:20673794
14. Chan LK, Koh WY, Muhammad TST. Comparison of Cytotoxic
Activities between in-vitro and Field Grown Plants of Typhonium
flagelliforme (Lodd.) Blume. Journal of Plant Biology. March 2005;
48(1): 25-31. http://dx.doi.org/10.1007/BF03030561
15. Zhong Z, Zhou G, Chen X, Huang P. Pharmacological study on the
extracts fro m Typhonium flagel liforme Bl ume. Zhong Yao Cai. Journal
of Chinese medicinal materials. 2001; 24(10):735-8.
Cite this article as:
Singh Mankaran, Kumar Dinesh, Sharma Deepak, Singh Gurmeet.
Typhonium flagelliforme: A multipurpose plant. Int. Res. J. Pharm. 2013;
4(3):45-48
Source of support: Nil, Conflict of interest: None Declared